Literature DB >> 14719614

Temporal and gender-related trends in brain metastases from lung and breast cancer.

Barbara P Yawn1, Peter C Wollan, Clayton Schroeder, Lilianna Gazzuola, Minesh Mehta.   

Abstract

Increased duration of cancer survival may allow a longer window for detection of metastases, including brain metastases. Using the entire population of Olmsted County, Minnesota, we looked at trends in the rate of brain metastases in people diagnosed with primary lung or breast cancers between January 1, 1988, and December 31, 2001. Yearly rates of brain metastases detection following the primary tumors were calculated from a combination of medical record and SEER database information. Trends in rates and gender differences were assessed. There was no discernible increase in the rates of brain metastases secondary to lung or breast cancer during the period of observation. However, women were twice as likely as men to have brain metastases detected following a primary lung cancer. This difference was constant over the time period. This twofold difference in brain metastases detected in women versus men with lung cancer deserves further evaluation and confirmation.

Entities:  

Mesh:

Year:  2003        PMID: 14719614

Source DB:  PubMed          Journal:  Minn Med        ISSN: 0026-556X


  21 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Attributes of brain metastases from breast and lung cancer.

Authors:  Kyle Hengel; Gurinder Sidhu; Jai Choi; Jeremy Weedon; Emmanuel Nwokedi; Constantine A Axiotis; Xianyuan Song; Albert S Braverman
Journal:  Int J Clin Oncol       Date:  2012-03-02       Impact factor: 3.402

3.  The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).

Authors:  Shoji Yomo; Toru Serizawa; Masaaki Yamamoto; Yoshinori Higuchi; Yasunori Sato; Takashi Shuto; Atsuya Akabane; Hidefumi Jokura; Jun Kawagishi; Hidefumi Aoyama
Journal:  J Neurooncol       Date:  2019-09-05       Impact factor: 4.130

4.  Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.

Authors:  Saiama N Waqar; Sadaf H Waqar; Kathryn Trinkaus; Carlos A Gadea; Cliff G Robinson; Jeffrey Bradley; Mark A Watson; Varun Puri; Ramaswamy Govindan; Daniel Morgensztern
Journal:  Am J Clin Oncol       Date:  2018-01       Impact factor: 2.339

5.  Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.

Authors:  Xiao-Xiao Dinglin; Yan Huang; Hui Liu; Yin-Duo Zeng; Xue Hou; Li-Kun Chen
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

Review 6.  Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.

Authors:  Rimas V Lukas; Maciej S Lesniak; Ravi Salgia
Journal:  CNS Oncol       Date:  2014-01

7.  Palliative stereotactic-endoscopic third ventriculostomy for the treatment of obstructive hydrocephalus from cerebral metastasis.

Authors:  Clark C Chen; Ekkehard Kasper; Peter Warnke
Journal:  Surg Neurol Int       Date:  2011-06-15

8.  An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib.

Authors:  Ying Zhang; Huaping Tang; Jun Li; Meng Li
Journal:  Onco Targets Ther       Date:  2015-06-08       Impact factor: 4.147

9.  Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.

Authors:  Yin-Duo Zeng; Hai Liao; Tao Qin; Li Zhang; Wei-Dong Wei; Jian-Zhong Liang; Fei Xu; Xiao-Xiao Dinglin; Shu-Xiang Ma; Li-Kun Chen
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  Hippocampal avoidance in prophylactic cranial irradiation for small cell lung cancer: benefits and pitfalls.

Authors:  Aswin George Abraham; Wilson Roa
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.